Blood test may predict heart device success
NCT ID NCT07469137
First seen Mar 14, 2026 · Last updated May 24, 2026 · Updated 6 times
Summary
This study looks at whether a substance called YKL-40 in the blood can help predict how well heart failure patients respond to a special pacemaker (CRT). Researchers will measure YKL-40 levels during the pacemaker procedure and check heart function 6 months later. About 51 adults with severe heart failure are taking part. The goal is to find a simple way to identify who will benefit most from CRT.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC RESYNCHRONISATION THERAPY (CRT) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Trakya University
Edirne, Edirne, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.